KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Acquisitions (2017 - 2024)

Idexx Laboratories has reported Acquisitions over the past 12 years, most recently at -$306000.0 for Q3 2024.

  • Quarterly results put Acquisitions at -$306000.0 for Q3 2024, changed N/A from a year ago — trailing twelve months through Jun 2025 was -$306000.0 (down 100.4% YoY), and the annual figure for FY2024 was $76.7 million, changed.
  • Acquisitions for Q3 2024 was -$306000.0 at Idexx Laboratories, down from $77.0 million in the prior quarter.
  • Over the last five years, Acquisitions for IDXX hit a ceiling of $152.1 million in Q2 2021 and a floor of -$306000.0 in Q3 2024.
  • Median Acquisitions over the past 4 years was $8.1 million (2021), compared with a mean of $32.9 million.
  • Biggest five-year swings in Acquisitions: plummeted 97.0% in 2020 and later skyrocketed 716.8% in 2021.
  • Idexx Laboratories' Acquisitions stood at $1.5 million in 2020, then surged by 716.8% to $12.3 million in 2021, then decreased by 6.04% to $11.5 million in 2022, then plummeted by 102.66% to -$306000.0 in 2024.
  • The last three reported values for Acquisitions were -$306000.0 (Q3 2024), $77.0 million (Q1 2024), and $11.5 million (Q3 2022) per Business Quant data.